We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PROG market cap is 20.97M. The company's latest EPS is USD -5.2360 and P/E is -0.17.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 542k | 318k | 32k |
| Operating Income | -23.32M | -13.34M | -15.52M | -15.79M | -16.23M |
| Net Income | -73.45M | -15.41M | -4.19M | 6.47M | -22.22M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 143.99M | 74.31M | 1.25M | 305k | 4k |
| Operating Income | -140.12M | -195.19M | -117.84M | -61.78M | -67.14M |
| Net Income | -228.83M | -192.8M | -247.41M | -38.16M | -124.12M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 34.7M | 31.22M | 22.99M | 18.26M | 0 |
| Total Liabilities | 153.49M | 132.64M | 123.18M | 107.59M | 0 |
| Total Equity | -118.79M | -101.42M | -100.19M | -89.32M | 0 |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 101.73M | 154.44M | 108.84M | 53.53M | 31.22M |
| Total Liabilities | 185.6M | 261.43M | 193.82M | 155.81M | 132.64M |
| Total Equity | -83.87M | -106.99M | -84.98M | -102.29M | -101.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -34.75M | -48.5M | -12.5M | -23.45M | N/A |
| Investing | -26k | 2.44M | 3.01M | 2.83M | N/A |
| Financing | 16.86M | 30.78M | 5.1M | 10.74M | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -106.12M | -165.74M | -167.49M | -64.42M | -48.5M |
| Investing | 16.53M | -4.94M | -1.24M | -792k | 2.44M |
| Financing | 73.64M | 229.72M | 165.05M | 7.3M | 30.78M |
| Market Cap | 20.97M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 4.4k |
| Price to Cash Ratio | 1.37 |
| Price to Book Ratio | -0.21 |
| Dividend Yield | - |
| Shares Outstanding | 23.7M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (0.62%) |
| Company Name | Biora Therapeutics Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.bioratherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
